Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection : a Single-Center 28-Day Study
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com..
BACKGROUND: Despite the ongoing spread of coronavirus disease 2019 (COVID-19), knowledge about factors affecting prolonged viral excretion is limited.
METHODS: In this study, we retrospectively collected data from 99 hospitalized patients with coronavirus disease 2019 (COVID-19) between 19 January and 17 February 2020 in Zhejiang Province, China. We classified them into 2 groups based on whether the virus test results eventually became negative. Cox proportional hazards regression was used to evaluate factors associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding.
RESULTS: Among 99 patients, 61 patients had SARS-CoV-2 clearance (virus-negative group), but 38 patients had sustained positive results (virus-positive group). The median duration of SARS-CoV-2 excretion was 15 (interquartile range, 12-19) days among the virus-negative patients. The shedding time was significantly increased if the fecal SARS-CoV-2 RNA test result was positive. Male sex (hazard ratio [HR], 0.58 [95% confidence interval {CI}, .35-.98]), immunoglobulin use (HR, 0.42 [95% CI, .24-.76]), APACHE II score (HR, 0.89 [95% CI, .84-.96]), and lymphocyte count (HR, 1.81 [95% CI, 1.05-3.1]) were independent factors associated with a prolonged duration of SARS-CoV-2 shedding. Antiviral therapy and corticosteroid treatment were not independent factors.
CONCLUSIONS: SARS-CoV-2 RNA clearance time was associated with sex, disease severity, and lymphocyte function. The current antiviral protocol and low-to-moderate dosage of corticosteroid had little effect on the duration of viral excretion.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:222 |
---|---|
Enthalten in: |
The Journal of infectious diseases - 222(2020), 6 vom: 17. Aug., Seite 910-918 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shi, Ding [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adrenal Cortex Hormones |
---|
Anmerkungen: |
Date Completed 28.08.2020 Date Revised 18.12.2020 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/infdis/jiaa388 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM311922171 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM311922171 | ||
003 | DE-627 | ||
005 | 20231225143309.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/infdis/jiaa388 |2 doi | |
028 | 5 | 2 | |a pubmed24n1039.xml |
035 | |a (DE-627)NLM311922171 | ||
035 | |a (NLM)32614392 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shi, Ding |e verfasserin |4 aut | |
245 | 1 | 0 | |a Clinical Characteristics and Factors Associated With Long-Term Viral Excretion in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection |b a Single-Center 28-Day Study |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 28.08.2020 | ||
500 | |a Date Revised 18.12.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissionsoup.com. | ||
520 | |a BACKGROUND: Despite the ongoing spread of coronavirus disease 2019 (COVID-19), knowledge about factors affecting prolonged viral excretion is limited | ||
520 | |a METHODS: In this study, we retrospectively collected data from 99 hospitalized patients with coronavirus disease 2019 (COVID-19) between 19 January and 17 February 2020 in Zhejiang Province, China. We classified them into 2 groups based on whether the virus test results eventually became negative. Cox proportional hazards regression was used to evaluate factors associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) shedding | ||
520 | |a RESULTS: Among 99 patients, 61 patients had SARS-CoV-2 clearance (virus-negative group), but 38 patients had sustained positive results (virus-positive group). The median duration of SARS-CoV-2 excretion was 15 (interquartile range, 12-19) days among the virus-negative patients. The shedding time was significantly increased if the fecal SARS-CoV-2 RNA test result was positive. Male sex (hazard ratio [HR], 0.58 [95% confidence interval {CI}, .35-.98]), immunoglobulin use (HR, 0.42 [95% CI, .24-.76]), APACHE II score (HR, 0.89 [95% CI, .84-.96]), and lymphocyte count (HR, 1.81 [95% CI, 1.05-3.1]) were independent factors associated with a prolonged duration of SARS-CoV-2 shedding. Antiviral therapy and corticosteroid treatment were not independent factors | ||
520 | |a CONCLUSIONS: SARS-CoV-2 RNA clearance time was associated with sex, disease severity, and lymphocyte function. The current antiviral protocol and low-to-moderate dosage of corticosteroid had little effect on the duration of viral excretion | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a SARS-CoV-2 | |
650 | 4 | |a disease severity | |
650 | 4 | |a lymphocyte function | |
650 | 4 | |a risk factors | |
650 | 4 | |a viral excretion | |
650 | 7 | |a Adrenal Cortex Hormones |2 NLM | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a RNA, Viral |2 NLM | |
700 | 1 | |a Wu, Wenrui |e verfasserin |4 aut | |
700 | 1 | |a Wang, Qing |e verfasserin |4 aut | |
700 | 1 | |a Xu, Kaijin |e verfasserin |4 aut | |
700 | 1 | |a Xie, Jiaojiao |e verfasserin |4 aut | |
700 | 1 | |a Wu, Jingjing |e verfasserin |4 aut | |
700 | 1 | |a Lv, Longxian |e verfasserin |4 aut | |
700 | 1 | |a Sheng, Jifang |e verfasserin |4 aut | |
700 | 1 | |a Guo, Jing |e verfasserin |4 aut | |
700 | 1 | |a Wang, Kaicen |e verfasserin |4 aut | |
700 | 1 | |a Fang, Daiqiong |e verfasserin |4 aut | |
700 | 1 | |a Li, Yating |e verfasserin |4 aut | |
700 | 1 | |a Li, Lanjuan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infectious diseases |d 1945 |g 222(2020), 6 vom: 17. Aug., Seite 910-918 |w (DE-627)NLM000005819 |x 1537-6613 |7 nnns |
773 | 1 | 8 | |g volume:222 |g year:2020 |g number:6 |g day:17 |g month:08 |g pages:910-918 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/infdis/jiaa388 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 222 |j 2020 |e 6 |b 17 |c 08 |h 910-918 |